GSK-101468/169

Study Sponsor: GSK

Study Title

A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel Group Study of Six Months Treatment with Ropinirole CR as Adjunctive Therapy in Patients with Parkinson's Disease who are not Optimally Controlled on L-dopa

Medicine or Vaccine (generic name)

ropinirole

Sponsor Identification Number

101468/169

Trial Registry Identification Number(#'s)

NCT00381472

Medical Condition

Parkinson Disease

Phase

Phase 3

Link to GSK Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=101468/169

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT00381472

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Extension study 101468/248 was conducted.

Date Added to this Site

June 2014